Search research articles
Contact Us
Filters
Showing results (331-340 of 470) with videos related to
Page
of 47
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 16, 2024
YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic Vulnerabilities
C Allison Stewart, Lixia Diao, Yuanxin Xi, et al.
Cancer Letters
|
June 18, 2026
Deep Learning of CT Imaging Predicts PD-L1 Expression and Immunotherapy Response in Metastatic NSCLC: A Multi-Center Study
Amgad Muneer, Eman Showkatian, Maliazurina B Saad, et al.
Cancers
|
November 13, 2025
Radiomics for Dynamic Lung Cancer Risk Prediction in USPSTF-Ineligible Patients
Morteza Salehjahromi, Hui Li, Eman Showkatian, et al.
Nature Communications
|
October 29, 2014
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
Limo Chen, Don L Gibbons, Sangeeta Goswami, et al.
Cancer Immunology, Immunotherapy : CII
|
April 18, 2020
<sup>18</sup>F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer
Kyle G Mitchell, Behrang Amini, Yunfei Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 21, 2020
A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer
Tina Cascone, Boris Sepesi, Heather Y Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 3, 2016
The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer
Vassiliki Papadimitrakopoulou, J Jack Lee, Ignacio I Wistuba, et al.
BMC Medicine
|
October 26, 2016
Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set
Jason Roszik, Lauren E Haydu, Kenneth R Hess, et al.
Nature Communications
|
August 20, 2021
Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer
Tina Cascone, Annikka Weissferdt, Myrna C B Godoy, et al.
Cancer Immunology Research
|
March 19, 2026
FOXM1-specific TCR-engineered T cells target non-small cell lung cancer
Emily Bontekoe, Minying Zhang, Peixin Jiang, et al.
Page
of 47
Search research articles
Search
Showing results (331-340 of 470) with videos related to
Sort By:
Page
of 47
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 16, 2024
YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic Vulnerabilities
C Allison Stewart, Lixia Diao, Yuanxin Xi, et al.
Cancer Letters
|
June 18, 2026
Deep Learning of CT Imaging Predicts PD-L1 Expression and Immunotherapy Response in Metastatic NSCLC: A Multi-Center Study
Amgad Muneer, Eman Showkatian, Maliazurina B Saad, et al.
Cancers
|
November 13, 2025
Radiomics for Dynamic Lung Cancer Risk Prediction in USPSTF-Ineligible Patients
Morteza Salehjahromi, Hui Li, Eman Showkatian, et al.
Nature Communications
|
October 29, 2014
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
Limo Chen, Don L Gibbons, Sangeeta Goswami, et al.
Cancer Immunology, Immunotherapy : CII
|
April 18, 2020
<sup>18</sup>F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer
Kyle G Mitchell, Behrang Amini, Yunfei Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 21, 2020
A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer
Tina Cascone, Boris Sepesi, Heather Y Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 3, 2016
The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer
Vassiliki Papadimitrakopoulou, J Jack Lee, Ignacio I Wistuba, et al.
BMC Medicine
|
October 26, 2016
Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set
Jason Roszik, Lauren E Haydu, Kenneth R Hess, et al.
Nature Communications
|
August 20, 2021
Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer
Tina Cascone, Annikka Weissferdt, Myrna C B Godoy, et al.
Cancer Immunology Research
|
March 19, 2026
FOXM1-specific TCR-engineered T cells target non-small cell lung cancer
Emily Bontekoe, Minying Zhang, Peixin Jiang, et al.
Page
of 47